The author discloses that she is currently serving on a women's health advisory board for Actavis Pharmaceuticals, for which she receives financial consideration.
A New Pharmacologic Treatment for Nausea and Vomiting of Pregnancy
Article first published online: 18 FEB 2014
© 2014 AWHONN
Nursing for Women's Health
Volume 18, Issue 1, pages 73–77, February/March 2014
How to Cite
Fantasia, H. C. (2014), A New Pharmacologic Treatment for Nausea and Vomiting of Pregnancy. Nursing for Women's Health, 18: 73–77. doi: 10.1111/1751-486X.12096
- Issue published online: 18 FEB 2014
- Article first published online: 18 FEB 2014
- morning sickness;
Nausea and vomiting of pregnancy (NVP) affects up to 80 percent of pregnant women. This condition is usually self-limiting, but the symptoms can be distressing and interfere with work, social activities and sleep. Symptoms can often be managed by diet and lifestyle changes, but these interventions may not be successful for everyone. In April 2013, the U.S. Food and Drug Administration approved doxylamine succinate 10 mg/pyridoxine hydrochloride 10 mg (Diclegis®) as the first medication to specifically treat NVP in more than 30 years. This article reviews the indications, dosage and nursing interventions associated with using doxylamine succinate/pyridoxine to treat NVP.